Rutebemberwa Elizeus, Mpeka Betty, Pariyo George, Peterson Stefan, Mworozi Edison, Bwanga Freddie, Källander Karin
a Makerere University School of Public Health , Kampala , Uganda .
b Abt Associates , Kampala , Uganda .
Ups J Med Sci. 2015;120(4):249-56. doi: 10.3109/03009734.2015.1072606. Epub 2015 Aug 25.
In Uganda, the main causes of death in children under 5 years of age are malaria and pneumonia--often due to delayed diagnosis and treatment. In preparation for a community case management intervention for pneumonia and malaria, the bacterial composition of the nasopharyngeal flora and its in vitro resistance were determined in children aged five or under to establish baseline resistance to commonly used antibiotics.
In a population-based survey in April 2008, nasopharyngeal specimens were collected from 152 randomly selected healthy children under 5 years of age in the Iganga/Mayuge Health and Demographic Surveillance Site (HDSS). Medical history and prior treatment were recorded. Demographic characteristics and risk factors for carriage of resistant strains were obtained from the HDSS census. Bacteria were isolated and analysed for antibiotic susceptibility using disk diffusion and E test.
Streptococcus pneumoniae (S. pneumoniae) carriage was 58.6%, and, while most (80.9%) isolates had intermediate resistance to penicillin, none was highly resistant. Whereas no isolate was resistant to erythromycin, 98.9% were resistant to trimethoprim-sulphamethoxazole (co-trimoxazole).
In vitro resistance in S. pneumoniae to co-trimoxazole treatment was high, and the majority of isolates had intermediate resistance to penicillin. To inform treatment policies on the clinical efficacy of current treatment protocols for pneumonia in health facilities and at the community level, routine surveillance of resistance in pneumonia pathogens is needed as well as research on treatment efficacy in cases with resistant strains. Improved clinical algorithms and diagnostics for pneumonia should be developed.
在乌干达,5岁以下儿童的主要死因是疟疾和肺炎,这通常是由于诊断和治疗延误所致。为筹备针对肺炎和疟疾的社区病例管理干预措施,对5岁及以下儿童的鼻咽部菌群的细菌组成及其体外耐药性进行了测定,以确定对常用抗生素的基线耐药性。
在2008年4月进行的一项基于人群的调查中,从伊甘加/马尤格卫生与人口监测点(HDSS)随机选取152名5岁以下健康儿童,采集其鼻咽部标本。记录病史和既往治疗情况。从HDSS人口普查中获取人口统计学特征和耐药菌株携带的危险因素。采用纸片扩散法和E试验分离细菌并分析其抗生素敏感性。
肺炎链球菌(S. pneumoniae)携带率为58.6%,虽然大多数(80.9%)分离株对青霉素呈中度耐药,但无高度耐药株。虽然没有分离株对红霉素耐药,但98.9%对甲氧苄啶-磺胺甲恶唑(复方新诺明)耐药。
肺炎链球菌对复方新诺明治疗的体外耐药性较高,且大多数分离株对青霉素呈中度耐药。为了为卫生机构和社区层面肺炎现行治疗方案的临床疗效提供治疗政策依据,需要对肺炎病原体的耐药性进行常规监测,并对耐药菌株病例的治疗效果进行研究。应开发改进的肺炎临床算法和诊断方法。